https://www.marketscreener.com/quote/stock/NEUROCRINE-BIOSCIENCES-IN-10163/news/Neurocrine-Biosciences-Reports-Positive-Interim-Results-from-Phase-II-Study-of-NBI-74788-in-Adults-28151010/?utm_source=telegram&utm_medium=social&utm_campaign=share